Opko Health (OPK) Receivables (2010 - 2026)

Opko Health has reported Receivables for 17 years, with the latest figure at $21.9 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables fell 15.08% year-over-year to $21.9 million; the trailing twelve-month figure through Mar 2026 stood at $21.9 million (down 15.08% YoY), and the FY2025 full-year result was $111.7 million, down 21.18% from the prior year.
• Receivables for Q1 2026 stood at $21.9 million, down from $111.7 million in the prior quarter.
• The five-year high for Receivables was $213.0 million in Q2 2023, with the low at $1.6 million in Q3 2023.
• Historically, Receivables has averaged $89.3 million across 5 years, with a median of $111.7 million in 2025.
• Annual changes were most pronounced in 2022 — Receivables surged 60513.96% — and 2024, when it tumbled 96.63%.
• Opko Health's Receivables stood at $127.3 million in 2022, then declined by 3.09% to $123.4 million in 2023, then climbed by 14.9% to $141.8 million in 2024, then fell by 21.18% to $111.7 million in 2025, then tumbled by 80.38% to $21.9 million in 2026.
• The last three Receivables figures came in at $21.9 million (Q1 2026), $111.7 million (Q4 2025), and $27.7 million (Q3 2025), per Business Quant data.